Evaluation and Prediction of the Effect of EECP on HR-NICE Patients

Recruiting N/A Interventional Study
Stroke, Ischemic
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
First Affiliated Hospital Xi'an Jiaotong University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Stroke is one of the most threatening causes of mortality and disability worldwide. High risk non-disabling ischemic cerebrovascular events (HR-NICE), defined by mild stroke complicating with greater than 50% atherosclerotic stenosis in intracranial or extracranial arteries, is more likely to develop severe stroke in future. Currently, the clinical treatment for HR-NICE patients is limited to dual…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * In accordance with the diagnostic criteria of Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018 * Patients who have had a clinically significant ischemic stroke for the first time and are currently stable * Unilateral internal carotid artery or m…
Contacts

Wanghuan Dun, doctor

0086-18092706568

wanghuandun@163.com

CONTACT